Insights

Innovative Therapeutics SystImmune is focused on developing novel bispecific and trispecific antibodies along with antibody-drug conjugates for cancer treatment, indicating a potential market for advanced biologics and targeted therapies.

Recent Research Engagement The company actively participates in major oncology conferences such as WCLC, ASCO, and ESMO Breast, showcasing ongoing clinical advancements and offering opportunities for collaboration or funding of upcoming research projects.

Leadership Expansion With new appointments of a CEO and a Senior Vice President in oncology, SystImmune is strengthening its executive team, which could lead to increased strategic partnerships and expanded market presence.

Financial Capacity Generating revenue between $50M and $100M, SystImmune shows solid financial health, positioning it as a viable partner or customer for biopharmaceutical suppliers and service providers.

Technological Focus The company's use of advanced platforms like Tableau, AngularJS, and C++ for development indicates a strong tech infrastructure, presenting opportunities for technology vendors or clinical data management collaborations.

SystImmune Tech Stack

SystImmune uses 8 technology products and services including Tableau Server, Microsoft 365, cPanel, and more. Explore SystImmune's tech stack below.

  • Tableau Server
    Advanced Analytics And Data Science
  • Microsoft 365
    Email
  • cPanel
    Hosting Panels
  • Dell
    IT Infrastructure
  • AngularJS
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Cisco Switches
    Network Hardware
  • C++
    Programming Languages

Media & News

SystImmune's Email Address Formats

SystImmune uses at least 1 format(s):
SystImmune Email FormatsExamplePercentage
First.Last@systimmune.comJohn.Doe@systimmune.com
47%
Last@systimmune.comDoe@systimmune.com
3%
First.Last@systimmune.comJohn.Doe@systimmune.com
47%
Last@systimmune.comDoe@systimmune.com
3%

Frequently Asked Questions

What is SystImmune's phone number?

Minus sign iconPlus sign icon
You can contact SystImmune's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SystImmune's official website and social media links?

Minus sign iconPlus sign icon
SystImmune's official website is systimmune.com and has social profiles on LinkedIn.

What is SystImmune's SIC code NAICS code?

Minus sign iconPlus sign icon
SystImmune's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SystImmune have currently?

Minus sign iconPlus sign icon
As of January 2026, SystImmune has approximately 111 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: J. D.Chief Medical Officer: J. C.Chief Of Staff: J. E.. Explore SystImmune's employee directory with LeadIQ.

What industry does SystImmune belong to?

Minus sign iconPlus sign icon
SystImmune operates in the Biotechnology Research industry.

What technology does SystImmune use?

Minus sign iconPlus sign icon
SystImmune's tech stack includes Tableau ServerMicrosoft 365cPanelDellAngularJSjQueryCisco SwitchesC++.

What is SystImmune's email format?

Minus sign iconPlus sign icon
SystImmune's email format typically follows the pattern of First.Last@systimmune.com. Find more SystImmune email formats with LeadIQ.

When was SystImmune founded?

Minus sign iconPlus sign icon
SystImmune was founded in 2014.

SystImmune

Biotechnology ResearchWashington, United States51-200 Employees

Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-drug conjugates (ADC's). Our objective is to create biologics that work through systematic intervention on the solid tumor micro-environment, to either directly attack the tumor and/or to activate the immune system to attack the tumor. We are a group of highly experienced immuno-oncology scientists utilizing several technology platforms to develop world class advanced antibody-based drug therapies.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $50M$100M

    SystImmune's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    SystImmune's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.